Fig. 1

Kaplan-Meier analyses of overall survival of 419 prostate cancer patients without (401 patients) and with (18 patients) lymph node (LN) recurrence
Kaplan-Meier analyses of overall survival of 419 prostate cancer patients without (401 patients) and with (18 patients) lymph node (LN) recurrence